The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Unexpected Role for IL-17 in Protective Immunity against Hypervirulent Mycobacterium tuberculosis HN878 Infection
Open accessAbstract
Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB), infects one third of the world's population. Among these infections, clinical isolates belonging to the W-Beijing appear to be emerging, representing about 50% of Mtb isolates in East Asia, and about 13% of all Mtb isolates worldwide. In animal models, infection with W-Beijing strain, Mtb HN878, is considered "hypervirulent" as it results in increased mortality and causes exacerbated immunopathology in infected animals. We had previously shown the Interleukin (IL) -17 pathway is dispensable for primary immunity against infection with the lab adapted Mtb H37Rv strain. However, it is not known whether IL-17 has any role to play in protective immunity against infection with clinical Mtb isolates. We report here that lab adapted Mtb strains, such as H37Rv, or less virulent Mtb clinical isolates, such as Mtb CDC1551, do not require IL-17 for protective immunity against infection while infection with Mtb HN878 requires IL-17 for early protective immunity. Unexpectedly, Mtb HN878 induces robust production of IL-1β through a TLR-2-dependent mechanism, which supports potent IL-17 responses. We also show that the role for IL-17 in mediating protective immunity against Mtb HN878 is through IL-17 Receptor signaling in non-hematopoietic cells, mediating the induction of the chemokine, CXCL-13, which is required for localization of T cells within lung lymphoid follicles. Correct T cell localization within lymphoid follicles in the lung is required for maximal macrophage activation and Mtb control. Since IL-17 has a critical role in vaccine-induced immunity against TB, our results have far reaching implications for the design of vaccines and therapies to prevent and treat emerging Mtb strains. In addition, our data changes the existing paradigm that IL-17 is dispensable for primary immunity against Mtb infection, and instead suggests a differential role for IL-17 in early protective immunity against emerging Mtb strains.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Khader, S. A., Bell, G. K., Pearl, J. E., Fountain, J. J., Rangel-Moreno, J., Cilley, G. E., Shen, F., Eaton, S. M., Gaffen, S. L., Swain, S. L., et al. (2007) · Nature Immunology · doi:10.1038/ni1449 · Cited by 1,439
Self-citationNurieva, R. I., Chung, Y., Hwang, D., Yang, X. O., Kang, H. S., Ma, L., Wang, Y.-H., Watowich, S. S., Jetten, A. M., Tian, Q., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.05.009 · Cited by 1,205
IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia
Aujla, S. J., Chan, Y. R., Zheng, M., Fei, M., Askew, D. J., Pociask, D. A., Reinhart, T. A., McAllister, F., Edeal, J., Gaus, K., et al. (2008) · Nature Medicine · doi:10.1038/nm1710 · Cited by 1,171
Self-citationNakae, S., Komiyama, Y., Nambu, A., Sudo, K., Iwase, M., Homma, I., Sekikawa, K., Asano, M., & Iwakura, Y. (2002) · Immunity · doi:10.1016/s1074-7613(02)00391-6 · Cited by 1,052
Sutton, C., Brereton, C., Keogh, B., Mills, K. H. G., & Lavelle, E. C. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060285 · Cited by 1,010
A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response
Reed, M. B., Domenech, P., Manca, C., Su, H., Barczak, A. K., Kreiswirth, B. N., Kaplan, G., & Barry, C. E. (2004) · Nature · doi:10.1038/nature02837 · Cited by 762
Predominance of a single genotype of Mycobacterium tuberculosis in countries of east Asia
van Soolingen, D., Qian, L., de Haas, P. E., Douglas, J. T., Traore, H., Portaels, F., Qing, H. Z., Enkhsaikan, D., Nymadawa, P., & van Embden, J. D. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.12.3234-3238.1995 · Cited by 706
Manca, C., Tsenova, L., Bergtold, A., Freeman, S., Tovey, M., Musser, J. M., Barry, C. E., Freedman, V. H., & Kaplan, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091096998 · Cited by 595
Worldwide Occurrence of Beijing/W Strains of Mycobacterium tuberculosis: A Systematic Review
Glynn, J. R., Whiteley, J., Bifani, P. J., Kremer, K., & van Soolingen, D. (2002) · Emerging Infectious Diseases · doi:10.3201/eid0805.020002 · Cited by 577
Umemura, M., Yahagi, A., Hamada, S., Begum, M. D., Watanabe, H., Kawakami, K., Suda, T., Sudo, K., Nakae, S., Iwakura, Y., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.6.3786 · Cited by 519
Global dissemination of the Mycobacterium tuberculosis W-Beijing family strains
Bifani, P. J., Mathema, B., Kurepina, N. E., & Kreiswirth, B. N. (2002) · Trends in Microbiology · doi:10.1016/s0966-842x(01)02277-6 · Cited by 500
Mycobacteria manipulate macrophage recruitment through coordinated use of membrane lipids
Cambier, C. J., Takaki, K. K., Larson, R. P., Hernandez, R. E., Tobin, D. M., Urdahl, K. B., Cosma, C. L., & Ramakrishnan, L. (2014) · Nature · doi:10.1038/nature12799 · Cited by 480
Khader, S. A., Pearl, J. E., Sakamoto, K., Gilmartin, L., Bell, G. K., Jelley-Gibbs, D. M., Ghilardi, N., deSauvage, F., & Cooper, A. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.2.788 · Cited by 472
Self-citationThe development of inducible bronchus-associated lymphoid tissue depends on IL-17
Rangel-Moreno, J., Carragher, D. M., de la Luz Garcia-Hernandez, M., Hwang, J. Y., Kusser, K., Hartson, L., Kolls, J. K., Khader, S. A., & Randall, T. D. (2011) · Nature Immunology · doi:10.1038/ni.2053 · Cited by 441
Self-citationScriba, T. J., Kalsdorf, B., Abrahams, D.-A., Isaacs, F., Hofmeister, J., Black, G., Hassan, H. Y., Wilkinson, R. J., Walzl, G., Gelderbloem, S. J., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.3.1962 · Cited by 410
Khader, S. A., Partida-Sanchez, S., Bell, G., Jelley-Gibbs, D. M., Swain, S., Pearl, J. E., Ghilardi, N., deSauvage, F. J., Lund, F. E., & Cooper, A. M. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052545 · Cited by 335
Self-citationManca, C., Tsenova, L., Freeman, S., Barczak, A. K., Tovey, M., Murray, P. J., Barry, C., & Kaplan, G. (2005) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2005.25.694 · Cited by 294
Lin, Y., Ritchea, S., Logar, A., Slight, S., Messmer, M., Rangel-Moreno, J., Guglani, L., Alcorn, J. F., Strawbridge, H., Park, S. M., et al. (2009) · Immunity · doi:10.1016/j.immuni.2009.08.025 · Cited by 289
Self-citationOrdway, D., Henao-Tamayo, M., Harton, M., Palanisamy, G., Troudt, J., Shanley, C., Basaraba, R. J., & Orme, I. M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.1.522 · Cited by 259
CXCR5+ T helper cells mediate protective immunity against tuberculosis
Slight, S. R., Rangel-Moreno, J., Gopal, R., Lin, Y., Fallert Junecko, B. A., Mehra, S., Selman, M., Becerril-Villanueva, E., Baquera-Heredia, J., Pavon, L., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65728 · Cited by 248
Self-citationReiley, W. W., Calayag, M. D., Wittmer, S. T., Huntington, J. L., Pearl, J. E., Fountain, J. J., Martino, C. A., Roberts, A. D., Cooper, A. M., Winslow, G. M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801496105 · Cited by 229
Definition of the Beijing/W Lineage of Mycobacterium tuberculosis on the Basis of Genetic Markers
Kremer, K., Glynn, J. R., Lillebaek, T., Niemann, S., Kurepina, N. E., Kreiswirth, B. N., Bifani, P. J., & van Soolingen, D. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.9.4040-4049.2004 · Cited by 228
Khader, S. A., Guglani, L., Rangel-Moreno, J., Gopal, R., Fallert Junecko, B. A., Fountain, J. J., Martino, C., Pearl, J. E., Tighe, M., Lin, Y.-Y., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101377 · Cited by 195
Self-citationSpread of Drug-Resistant Pulmonary Tuberculosis in Estonia
Krüüner, A., Hoffner, S. E., Sillastu, H., Danilovits, M., Levina, K., Svenson, S. B., Ghebremichael, S., Koivula, T., & Källenius, G. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.9.3339-3345.2001 · Cited by 190
The role of Th17 cytokines in primary mucosal immunity
Kolls, J. K., & Khader, S. A. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2010.11.002 · Cited by 176
Self-citationInterleukin 17-Producing γδ T Cells Increased in Patients with Active Pulmonary Tuberculosis
Peng, M., Wang, Z., Yao, C., Jiang, L., Jin, Q., Wang, J., & Li, B. (2008) · Cellular & Molecular Immunology · doi:10.1038/cmi.2008.25 · Cited by 173
Bai, H., Cheng, J., Gao, X., Joyee, A. G., Fan, Y., Wang, S., Jiao, L., Yao, Z., & Yang, X. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901584 · Cited by 168
Interleukin-17-dependent CXCL13 mediates mucosal vaccine–induced immunity against tuberculosis
Gopal, R., Rangel-Moreno, J., Slight, S., Lin, Y., Nawar, H. F., Fallert Junecko, B. A., Reinhart, T. A., Kolls, J., Randall, T. D., Connell, T. D., et al. (2013) · Mucosal Immunology · doi:10.1038/mi.2012.135 · Cited by 167
Self-citationJurado, J. O., Pasquinelli, V., Alvarez, I. B., Peña, D., Rovetta, A. I., Tateosian, N. L., Romeo, H. E., Musella, R. M., Palmero, D., Chuluyán, H. E., et al. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.1211619 · Cited by 161
Reduced Th17 Response in Patients with Tuberculosis Correlates with IL-6R Expression on CD4+ T Cells
Chen, X., Zhang, M., Liao, M., Graner, M. W., Wu, C. Y., Yang, Q., Liu, H., & Zhou, B. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200909-1463oc · Cited by 143
Sinsimer, D., Huet, G., Manca, C., Tsenova, L., Koo, M.-S., Kurepina, N. E., Kana, B. D., Mathema, B., Marras, S. A. E., Kreiswirth, B. N., et al. (2008) · Infection and Immunity · doi:10.1128/iai.01663-07 · Cited by 139
Agerton, T., Valway, S. E., Blinkhorn, R., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/520187 · Cited by 127
Khader, S. A., Rangel‐Moreno, J., Fountain, J. J., Martino, C. A., Reiley, W. W., Pearl, J. E., Winslow, G. M., Woodland, D. L., Randall, T. D., & Cooper, A. M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901937 · Cited by 125
Self-citationSchulz, S. M., Köhler, G., Schütze, N., Knauer, J., Straubinger, R. K., Chackerian, A. A., Witte, E., Wolk, K., Sabat, R., Iwakura, Y., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.11.7891 · Cited by 118
Kleinnijenhuis, J., Joosten, L. A. B., van de Veerdonk, F. L., Savage, N. D. L., van Crevel, R., Kullberg, B. J., van der Ven, A. J. A. M., Ottenhoff, T. H. M., Dinarello, C. A., van der Meer, J. W. M., et al. (2009) · European Journal of Immunology · doi:10.1002/eji.200839115 · Cited by 91
Caws, M., Thwaites, G. E., Stepniewska, K., Lan, N. T. N., Duyen, N. T., Phuong, N. T., Huyen, M. N. T., Phan, M., Loc, T. H., Chau, T. T. H., et al. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.01181-06 · Cited by 83
Ordway, D. J., Shang, S., Henao-Tamayo, M. I., et al. (2011) · Clinical and Vaccine Immunology · doi:10.1128/cvi.05127-11 · Cited by 77
Yoshida, A., Inagawa, H., Kohchi, C., Nishizawa, T., & Soma, G. (2009) · PubMed · Cited by 41
Stern, J. N. H., Keskin, D. B., Romero, V. A., Zúñiga, J., Encinales, L., Li, C., Awad, C., & Yunis, E. J. (2008) · Immunologic Research · doi:10.1007/s12026-008-8024-2 · Cited by 40
Cited by
IL-17 receptor–based signaling and implications for disease
Li, X., Bechara, R., Zhao, J., McGeachy, M. J., & Gaffen, S. L. (2019) · Nature Immunology · doi:10.1038/s41590-019-0514-y · Cited by 548
The IL-17 family in diseases: from bench to bedside
Huangfu, L., Li, R., Huang, Y., & Wang, S. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01620-3 · Cited by 452
Cytokines and Chemokines in Mycobacterium tuberculosis Infection
Domingo-Gonzalez, R., Prince, O., Cooper, A., & Khader, S. A. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.tbtb2-0018-2016 · Cited by 404
Self-citationT cells and adaptive immunity to Mycobacterium tuberculosis in humans
Jasenosky, L. D., Scriba, T. J., Hanekom, W. A., & Goldfeld, A. E. (2015) · Immunological Reviews · doi:10.1111/imr.12274 · Cited by 362
Th1 and Th17 Cells in Tuberculosis: Protection, Pathology, and Biomarkers
Lyadova, I. V., & Panteleev, A. V. (2015) · Mediators of Inflammation · doi:10.1155/2015/854507 · Cited by 327
Metadata
- Authors
- Gopal, R., Monin, L., Slight, S., Uche, U., Blanchard, E., A. Fallert Junecko, B., Ramos-Payan, R., Stallings, C. L., Reinhart, T. A., Kolls, J. K., Kaushal, D., Nagarajan, U., Rangel-Moreno, J., & Khader, S. A.
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-05-15
- Volume
- 10
- Issue
- 5
- Pages
- e1004099
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- OpenAlex
- W2069064769
- Cited by
- 274
- References
- 39
- FWCI
- 16.87
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.